Justin Fang
Senior Scientist, Amplitude Therapeutics
Justin Fang is a Formulations Scientist at RNA NewCo, with prior experience at Beam Therapeutics. His work focuses on lipid-based formulation development for RNA therapeutics, supporting the design and optimisation of delivery systems for genetic medicines. He holds a PhD in Bioengineering from the University of Connecticut, with additional experience in biomedical engineering and translational research.
Seminars
Thursday 19th November 2026
The Application of Trans-Amplifying RNA in Targeted & Untargeted LNP Systems
9:00 am
- Characterize the unique analytical requirements of trans-amplifying RNA systems, including multi component payload composition, RNA integrity, and encapsulation performance
- Compare targeted and untargeted LNP approaches to understand how delivery strategy influences cargo behavior and analytical requirements
- Develop analytical frameworks that connect cargo quality to potency, comparability, and translational readiness